Table 2.
Distribution of COL1A1gene Sp1 as well as ESR gene PvuuII and XbaI polymorphisms in the two groups
| Patient | Control | |||
|---|---|---|---|---|
| COL1A1 Sp1 | n=19 | % | n=20 | % |
| SS | 5 | 26.3 | 9 | 45.0 |
| Ss | 11 | 57.9 | 9 | 45.0 |
| ss | 3 | 15.8 | 2 | 10.0 |
| ESR 1 PvuII | n=19 | % | n=20 | % |
| PP | 5 | 26.3 | 8 | 40.0 |
| Pp | 9 | 47.4 | 8 | 40.0 |
| pp | 5 | 26.3 | 4 | 20.0 |
| ESR 1 XbaI | n=16 | % | n=19 | % |
| XX | 4 | 25.0 | 9 | 47.4 |
| Xx | 8 | 50.0 | 7 | 36.8 |
| xx | 4 | 25.0 | 3 | 15.8 |
The restriction fragment length polymorphisms (RFLPs) were coded as Ss (Sp1), Pp (Pvull), and Xx (Xbal). The uppercase letter signifies absence of the site, and the lowercase letter signifies presence of the site.